| 1 |
34890285 | Synergistic inhibitory effects of 5-aza-2'-deoxycytidine and cisplatin on urothelial carcinoma growth via suppression of TGFBI-MAPK signaling pathways. | 2022 Apr |
1 |
| 2 |
35454385 | Eribulin Mesylate Improves Cisplatin-Induced Cytotoxicity of Triple-Negative Breast Cancer by Extracellular Signal-Regulated Kinase 1/2 Activation. | 2022 Apr 15 |
3 |
| 3 |
33469371 | LncRNA BANCR Attenuates the Killing Capacity of Cisplatin on Gastric Cancer Cell Through the ERK1/2 Pathway. | 2021 |
2 |
| 4 |
33478150 | Impact of Selected Signaling Proteins on SNAIL 1 and SNAIL 2 Expression in Ovarian Cancer Cell Lines in Relation to Cells' Cisplatin Resistance and EMT Markers Level. | 2021 Jan 19 |
1 |
| 5 |
33792844 | Trans-ferulic acid ameliorates cisplatin-induced testicular damage via suppression of TLR4, P38-MAPK, and ERK1/2 signaling pathways. | 2021 Aug |
1 |
| 6 |
33813077 | Suppressing CHD1L reduces the proliferation and chemoresistance in osteosarcoma. | 2021 May 21 |
1 |
| 7 |
34068624 | Targeting SIRT2 Sensitizes Melanoma Cells to Cisplatin via an EGFR-Dependent Mechanism. | 2021 May 10 |
1 |
| 8 |
34078815 | Protective Effect of Panduratin A on Cisplatin-Induced Apoptosis of Human Renal Proximal Tubular Cells and Acute Kidney Injury in Mice. | 2021 |
2 |
| 9 |
34365218 | Predicting response to platinum and non-platinum drugs through bioluminescence resonance energy transfer (BRET) based bio-molecular interactions in platinum resistant epithelial ovarian cancer. | 2021 Nov |
1 |
| 10 |
34458953 | RETRACTED ARTICLE: Reduced LINC00467 elevates microRNA-125a-3p to suppress cisplatin resistance in non-small cell lung cancer through inhibiting sirtuin 6 and inactivating the ERK1/2 signaling pathway. | 2021 Aug 30 |
1 |
| 11 |
34571081 | STAT3β disrupted mitochondrial electron transport chain enhances chemosensitivity by inducing pyroptosis in esophageal squamous cell carcinoma. | 2021 Dec 1 |
1 |
| 12 |
34789301 | Ghrelin enhances cisplatin sensitivity in HO-8910 PM human ovarian cancer cells. | 2021 Nov 17 |
1 |
| 13 |
32102425 | Non-Phosphorylatable PEA-15 Sensitises SKOV-3 Ovarian Cancer Cells to Cisplatin. | 2020 Feb 24 |
1 |
| 14 |
32766794 | Correction: Cisplatin contributes to programmed death-ligand 1 expression in bladder cancer through ERK1/2-AP-1 signaling pathway. | 2020 Aug 28 |
1 |
| 15 |
31022663 | Celastrol, a plant-derived triterpene, induces cisplatin-resistance nasopharyngeal carcinoma cancer cell apoptosis though ERK1/2 and p38 MAPK signaling pathway. | 2019 May |
2 |
| 16 |
31312250 | Overexpression of P16 reversed the MDR1-mediated DDP resistance in the cervical adenocarcinoma by activating the ERK1/2 signaling pathway. | 2019 |
2 |
| 17 |
31341011 | Cisplatin contributes to programmed death-ligand 1 expression in bladder cancer through ERK1/2-AP-1 signaling pathway. | 2019 Sep 30 |
2 |
| 18 |
31378887 | MiR-129 reduces CDDP resistance in gastric cancer cells by inhibiting MAPK3. | 2019 Aug |
3 |
| 19 |
31440159 | The Role of Prostaglandin-Endoperoxide Synthase-2 in Chemoresistance of Non-Small Cell Lung Cancer. | 2019 |
1 |
| 20 |
31518663 | Cisplatin induces chemoresistance through the PTGS2-mediated anti-apoptosis in gastric cancer. | 2019 Nov |
3 |
| 21 |
31538075 | Effects of genistein on anti-tumor activity of cisplatin in human cervical cancer cell lines. | 2019 Sep |
1 |
| 22 |
31798724 | Cisplatin effect on head and neck squamous cell carcinoma cells is modulated by ERK1/2 protein kinases. | 2019 Dec |
1 |
| 23 |
28287251 | Cisplatin induced apoptosis of ovarian cancer A2780s cells by activation of ERK/p53/PUMA signals. | 2018 Jan |
6 |
| 24 |
29130514 | Involvement of Src signaling in the synergistic effect between cisplatin and digoxin on cancer cell viability. | 2018 Apr |
2 |
| 25 |
29247711 | Hexokinase 2 confers resistance to cisplatin in ovarian cancer cells by enhancing cisplatin-induced autophagy. | 2018 Feb |
2 |
| 26 |
29352505 | p53-independent Noxa induction by cisplatin is regulated by ATF3/ATF4 in head and neck squamous cell carcinoma cells. | 2018 Jun |
1 |
| 27 |
29372560 | Inhibition of the CSF-1 receptor sensitizes ovarian cancer cells to cisplatin. | 2018 Mar |
1 |
| 28 |
29373150 | Overexpressed SIRT6 attenuates cisplatin-induced acute kidney injury by inhibiting ERK1/2 signaling. | 2018 Apr |
1 |
| 29 |
29565706 | LncRNA NEAT1/let-7a-5p axis regulates the cisplatin resistance in nasopharyngeal carcinoma by targeting Rsf-1 and modulating the Ras-MAPK pathway. | 2018 Jun 3 |
2 |
| 30 |
29724868 | Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth In Vivo. | 2018 Aug 1 |
1 |
| 31 |
29731988 | Cisplatin-induced ERK1/2 activity promotes G1 to S phase progression which leads to chemoresistance of ovarian cancer cells. | 2018 Apr 13 |
8 |
| 32 |
30522099 | miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway. | 2018 |
1 |
| 33 |
27995416 | Synergistic action of cisplatin and echistatin in MDA-MB-231 breast cancer cells. | 2017 Mar |
1 |
| 34 |
28598976 | The dynamic role of autophagy and MAPK signaling in determining cell fate under cisplatin stress in osteosarcoma cells. | 2017 |
3 |
| 35 |
28703809 | Epigallocatechin-3-gallate, a prototypic chemopreventative agent for protection against cisplatin-based ototoxicity. | 2017 Jul 13 |
1 |
| 36 |
29344202 | Metformin in combination with cisplatin inhibits cell viability and induces apoptosis of human ovarian cancer cells by inactivating ERK 1/2. | 2017 Dec |
1 |
| 37 |
26331987 | Increasing 3D Matrix Rigidity Strengthens Proliferation and Spheroid Development of Human Liver Cells in a Constant Growth Factor Environment. | 2016 Mar |
1 |
| 38 |
26794135 | Knockdown of MACC1 expression increases cisplatin sensitivity in cisplatin-resistant epithelial ovarian cancer cells. | 2016 Apr |
1 |
| 39 |
27564099 | Curcumin potentiates antitumor activity of cisplatin in bladder cancer cell lines via ROS-mediated activation of ERK1/2. | 2016 Sep 27 |
3 |
| 40 |
27656839 | Knockdown of PARP-1 Inhibits Proliferation and ERK Signals, Increasing Drug Sensitivity in Osteosarcoma U2OS Cells. | 2016 |
1 |
| 41 |
25765877 | Platinum-induced neurotoxicity and preventive strategies: past, present, and future. | 2015 Apr |
1 |
| 42 |
25770930 | Combination of chrysin and cisplatin promotes the apoptosis of Hep G2 cells by up-regulating p53. | 2015 May 5 |
1 |
| 43 |
25879333 | The effects of combination of gefitinib and cisplatin on tongue squamous cell carcinoma cell lines. | 2015 Jan-Mar |
1 |
| 44 |
26249763 | Relevance of subcellular localization of extracellular signal-regulated kinase 1/2 (ERK1/2) for cisplatin resistance. | 2015 Dec |
1 |
| 45 |
26300055 | PKC-δ/PKC-α activity balance regulates the lethal effects of cisplatin. | 2015 Nov 1 |
1 |
| 46 |
23904094 | Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cells. | 2014 Feb 1 |
1 |
| 47 |
24751980 | Secreted clusterin gene silencing enhances chemosensitivity of a549 cells to cisplatin through AKT and ERK1/2 pathways in vitro. | 2014 |
1 |
| 48 |
24944268 | Magnesium protects against cisplatin-induced acute kidney injury by regulating platinum accumulation. | 2014 Aug 15 |
1 |
| 49 |
25099161 | PIM2 kinase is induced by cisplatin in ovarian cancer cells and limits drug efficacy. | 2014 Nov 7 |
1 |
| 50 |
25106434 | Secreted clusterin (sCLU) regulates cell proliferation and chemosensitivity to cisplatin by modulating ERK1/2 signals in human osteosarcoma cells. | 2014 Aug 9 |
1 |